John Cena, 48, says getting this cosmetic procedure 'completely changed' his life
In an interview with People published on Wednesday, Cena spoke about retiring from the WWE and the realities of aging, including his experience with hair loss.
"As I was trying to hide my hair loss, the audience was bringing it to light," he told People. "I saw their signs that said 'The bald John Cena.'"
The 17-time WWE world champion said the public scrutiny around his appearance "pushed him" to find ways to deal with hair loss.
"I now have a routine: red-light therapy, minoxidil, vitamins, shampoo, conditioner — and I also got a hair transplant last November," Cena said. "I hate the fact that if there wasn't so much shame around it, I'd have gotten it done 10 years ago."
The wrestler said he thought he was "alone" in his struggle, but eventually realized how common hair loss was among men.
The procedure was simple, Cena said: "They don't do anything except move your hair, one by one, from one area to another."
He added that he isn't embarrassed to talk about his hair transplant experience.
"If somebody's going to sweat me for that, I don't think there's any shame in that," Cena said. "It completely changed the course of my life."
As he looks beyond wrestling, he believes a fuller hairline might help him land a broader range of roles.
"A different hairstyle can identify a part that can get me more work, do the thing I love to do," he added.
A representative for Cena did not immediately respond to a request for comment sent by Business Insider outside regular hours.
Male pattern baldness, or androgenetic alopecia, accounts for over 95% of hair loss in men, per data from the American Hair Loss Association, a nonprofit organization. Around 25% of men with male pattern baldness start losing hair before age 21.
There are two FDA-approved medications for male pattern baldness, while other treatment options include laser therapy, platelet-rich plasma, and hair transplants.
In recent years, Turkey has made a name for itself as the go-to destination for hair transplant surgery. Around one million people traveled to Turkey for hair transplants in 2022, the head of the Turkish Health Tourism Association told local news agency Anadolu.
There's also been a trend of white-collar men in the US spending thousands on plastic surgery, fillers, and other self-care routines to look good, especially at work.
Data from the 2023 American Society of Plastic Surgeons procedural statistics report showed that men accounted for 6% of cosmetic procedures overall. In 2023, facelifts among men rose by 17%, nose reshaping increased by 10%, and eyelid surgery increased by 9% compared to the previous year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
3 hours ago
- San Francisco Chronicle
UCSF doctor reinstated at FDA less than 2 weeks after resigning amid MAGA backlash
A divisive UCSF oncologist has reportedly been reinstated at the FDA less than two weeks after he resigned amid criticism from President Donald Trump's allies. Multiple media outlets on Saturday cited Health and Human Services Department officials confirming the reinstatement of Dr. Vinay Prasad, which was first reported by Endpoints News, a biotech-focused news organization. Spokespeople for HHS, which oversees the Food and Drug Administration, did not immediately respond to inquiries from the Chronicle about the news. Prasad resigned as the FDA's chief medical and scientific officer in late July after right-wing provocateur Laura Loomer and former Sen. Rick Santorum, R-Pa., accused him of being too liberal. He also drew backlash for criticizing the FDA's 2023 approval of a gene therapy for Duchenne muscular dystrophy, a degenerative muscle disease that affects boys, who often do not survive past their 20s. In his role at the FDA overseeing vaccines, Prasad announced in May that the agency would limit updated COVID-19 vaccine access to seniors and people with certain people with certain medical conditions. Previously, the FDA had recommended annual COVID shots for all Americans over 6 months old. On social media, Loomer criticized Prasad's reinstatement, calling him a 'longtime progressive Marxist.' 'In the coming weeks, I will be ramping up my exposes (sic) of officials within HHS and FDA so the American people can see more of the pay for play rot themselves and how rabid Trump haters continue to be hired in the Trump administration,' she wrote. 'Should be a good time.'
Yahoo
7 hours ago
- Yahoo
DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™
TechLive™ is a vendor-agnostic integrated solution enabling remote scanning of MR, CT, PET/CT, and Ultrasound procedures Amidst radiology technologist shortages, remote scanning in a command center configuration enables the workforce to scan at multiple locations simultaneously with a high level of expertise RadNet has connected more than 300 MR, CT, PET/CT, and Ultrasound systems with TechLive™, delivering operational efficiency and increased access to advanced procedures LOS ANGELES and SOMERVILLE, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and global leader in AI-powered health informatics, announced today that it has received FDA 510(k) clearance for TechLive™ - a remote scanning solution enabling centralized operation and supervision of MR, CT, PET/CT, and Ultrasound procedures. Amidst tech labor shortages and inflationary wage pressure, TechLive™ empowers technologists to scan for multiple locations, enables improved operational efficiency, extends center operating hours, and enhances access to complex procedures. More than 300 of RadNet's MR, CT, PET/CT, and Ultrasound systems are now connected with DeepHealth's TechLive™ solution, resulting in increased patient throughput and improved quality through remotely matching expert staff with complex modalities in real-time. Over the past decade, radiology workloads have steadily increased, while the number of qualified technologists have not grown proportionally. In a pilot deployment at 64 locations inside of RadNet's New York area facilities, TechLive™ significantly contributed to a 42% decrease in MRI room closure hours during the second quarter of 2025 as compared with the same period in 2024, allowing more patients to receive timely scans. Additionally, as a result of the remote expert involvement during the same pilot deployment, TechLive™ contributed to an increase in complex procedures. Furthermore, in extending remote scanning capabilities to Ultrasound, TechLive™ is enabling experienced senior sonographers and physicians to remotely guide technologists on-site through complex cases in a modality that is heavily dependent upon real-time, operator expertise. "TechLive™ represents a paradigm shift in how we approach imaging operations," said Sham Sokka, PhD, Chief Operating and Technology Officer at DeepHealth. "By enabling real-time remote expertise, we are not only addressing today's staffing challenges, we are creating a foundation for more efficient, financially sustainable, and high-quality patient care across the broadest set of imaging modalities. This FDA clearance validates DeepHealth's vision of a connected imaging ecosystem that scales human expertise beyond physical boundaries." About DeepHealthDeepHealth is a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and serves as the umbrella brand for all companies within RadNet's Digital Health segment. DeepHealth provides AI-powered health informatics with the aim of empowering breakthroughs in care through imaging. Building on the strengths of the companies it has integrated and is rebranding (e.g., eRAD Radiology Information and Image Management Systems and Picture Archiving and Communication System, Aidence lung AI, DeepHealth, Kheiron, and iCAD breast AI, Quantib prostate and brain AI, and See-Mode thyroid and breast AI), DeepHealth leverages advanced AI for operational efficiency and improved clinical outcomes in lung, breast, prostate, and brain health. At the heart of DeepHealth's portfolio is a cloud-native operating system – DeepHealth OS – that unifies data across the clinical and operational workflow and personalizes AI-powered workspaces for everyone in the radiology continuum. Thousands of radiologists at hundreds of imaging centers and radiology departments around the world use DeepHealth solutions to enable earlier, more reliable, and more efficient disease detection, including in large-scale cancer screening programs. DeepHealth's human-centered, intuitive technology aims to push the boundaries of what's possible in healthcare. About RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 401 owned and/or operated outpatient imaging centers. RadNet's markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has a total of over 11,000 employees. For more information, visit DeepHealth ContactAndra AxenteDirector of Communications+ RadNet, Inc. ContactMark StolperExecutive Vice President and Chief Financial Officer310-445-2800 Forward-Looking Statements This communication contains certain 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by words such as: 'anticipate,' 'believe,' 'could,' 'estimate,' 'expect,' 'forecast,' 'intend,' 'may,' 'outlook,' 'plan,' 'potential,' 'possible,' 'predict,' 'project,' 'seek, 'should,' 'target,' 'will' or 'would,' the negative of these words, and similar references to future periods. Examples of forward-looking statements include statements regarding the streamlining of delivery and deployment across healthcare facilities, and TechLive creating a foundation for more efficient, financially sustainable and high-quality patient care across the broadest set of imaging modalities, and are qualified by the inherent risks and uncertainties surrounding future expectations generally, all of which are subject to change. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties, many of which are beyond RadNet's control. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management's current beliefs, expectations and assumptions regarding the future of RadNet's business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of RadNet's control. RadNet's actual results and financial condition may differ materially from those indicated in the forward-looking statements as a result of various factors. Neither RadNet nor its directors, executive officers, or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur, or if any of them do occur, what impact they will have on the business, results of operations or financial condition of RadNet. Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on RadNet's business and the ability to realize the expected benefits of the acquisition. Risks and uncertainties that could cause results to differ from expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the technology, and (2) the risk of legislative, regulatory, economic, competitive, and technological changes. The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included elsewhere. Additional information concerning risks, uncertainties and assumptions can be found in RadNet's filings with the Securities and Exchange Commission (the 'SEC'), including the risk factors discussed in RadNet's most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and future filings with the SEC. Forward-looking statements included herein are made only as of the date hereof and, except as required by applicable law, RadNet does not undertake any obligation to update any forward-looking statements, or any other information in this communication, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.
New York Post
10 hours ago
- New York Post
FDA pulls popular ice cream from shelves after packaging mix up: ‘Serious allergic reaction'
Ice cream lovers may have more than a meltdown. Friendly's Ice Cream has recalled one of its most popular flavors after a packaging mix up sparking an allergy risk warning from the Food and Drug Administration, which who said it could cause 'a serious or life-threatening allergic reaction.' DFA Dairy Brands, LLC, voluntarily pulled 324 cartons of its 48-fluid-ounce Friendly's Cookies & Cream ice cream from stores after they were packaged in Vanilla Bean containers but topped with Cookies & Cream lids, the FDA said. 3 Friendly's Ice Cream their Cookies & Cream ice cream from stores across the nation. Paul Weaver/SOPA Images / Shutterstock The Vanilla Bean flavor does not contain soy or wheat, which are present in Cookies & Cream. Therefore, the Vanilla Bean cartons don't list those ingredients, according to the FDA. 'For many people, a reaction to soy or wheat usually means abdominal pain, but you could get a rash, or less commonly, asthma-like symptoms,' said Dr. Joseph Raduazzo, an internal medicine specialist in Massachusetts. 3 Federal officials are warning that the mislabeling could have deadly consequences for allergy sufferers. friendlys 'For people with a severe allergy to soy or wheat, the reaction could be life-threatening, similar to when people with peanut allergies come into contact with the nut.' No illnesses or adverse reactions have been reported due to the mispackaging, according to the FDA website. The recalled ice cream was distributed through a single distribution center, UNFI, to retail stores in Maryland, Virginia and Pennsylvania, the agency said. 3 The recall was issued due to the Food and Drug Administration saying in what was a package mix-up that the 324 cartons of ice cream posed an allergy risk that can cause 'a serious or life-threatening allergic reaction.' REUTERS No other Friendly's products were included, a recorded message on a Friendly's consumer hotline said. Last month, Florida-based Rich's Ice Cream recalled over 100,000 ice cream bars in 23 states – including New York and Pennsylvania – due to listeria concerns. The voluntary removal from the market was one of the largest ice cream recalls in recent history.
